Metadata
- Name
- Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT01275287
- Description
- The purpose of this research study is to see if Eculizumab (Soliris®) can safely be used in
addition to conventional therapy in patients with active ANCA (Antineutrophil Cytoplasmic
Autoantibodies ) vasculitis and lead to a more rapid decrease in disease activity.
ANCA vasculitis is an inflammation of the small vessels whereby ANCA antibodies
inappropriately activate one's own white blood cells (neutrophils) and cause damage to the
small blood vessels. - Data or Study Types
- clinical trial
- Keywords
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Complement Activation
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2010
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT01275287
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT01275287